AstraZeneca disinvest hypertension medicines to Atnahs Pharma
AstraZeneca divest its global commercial rights of Inderal (propranolol), Tenormin (atenolol), Tenoretic (atenolol, chlorthalidone fixed-dose combination), Zestril (lisinopril) and Zestoretic (lisinopril, hydrochlorothiazide... Read More
Case Study: AstraZeneca to sublicense its global rights to Movantik
AstraZeneca has agreed to sublicense its global rights to Movantik (naloxegol), excluding Europe, Canada and Israel, to RedHill Biopharma (RedHill). Movantik is... Read More
Takeda Divesting Select OTC and Non-core Assets of takeda to Acino
Posted on25 Oct 2019
Tagsdisinvestment in pharma business, divestiment in pharma, Divestment in pharma, Takeda, Takeda acquires shire
Comments0
Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select over-the-counter (OTC) and prescription... Read More
AstraZeneca divests Losec (omeprazole) and associated brands rights to Cheplapharm Arzneimittel GmbH
Posted on03 Oct 2019
TagsAcimax, Antra, AstraZeneca, Cheplapharm Arzneimittel GmbH, disinvestment in pharma business, Losec, Mepral, Mopral, Omepral, Zoltum
Comments0
AstraZeneca has agreed to sell the global commercial rights, excluding China, Japan, the US and Mexico, for Losec (omeprazole) and associated brands... Read More
Biocon Ltd acquired a R&D facility from Pfizer
Posted on25 Sep 2019
Comments0
Biocon Ltd has acquired a Chennai-based research and development (R&D) facility from Pfizer Healthcare India Ltd through its subsidiary Biocon Biologics. The... Read More
Sanofi India announces sale of its Ankleshwar facility to Zentiva
Sanofi India Ltd announced sale of its manufacturing facility at Ankleshwar in Gujarat to Zentiva Pvt Ltd. Incorporated in May 1956 under... Read More
GSK’s disinvestment of Chiron Behring to Bharat Biotech
Posted on16 Feb 2019
Tagsacquisition in pharma, Bharat Biotech, Chiron Behring Vaccines, disinvestment in pharma business, GSK, Hoechst AG
Comments0
Bharat Biotech’s recent plans to acquire Chiron Behring Vaccine Private Limited from GlaxoSmithKline Asia, is expected to boost the company’s rabies vaccine... Read More
Strides Shasun to disinvest India Generic Business; Eris Lifescience to acquire at 500 Crores
Eris Lifesciences has entered into a definitive agreement to acquire India branded generics business of Strides Shasun for an aggregate cash consideration... Read More
AstraZeneca outlicense lung disease to Mereo BioPharma
AstraZeneca is licensing exclusive rights of AZD9668 — an oral inhibitor of an enzyme called neutrophil elastase for lung disease to Mereo... Read More